The purpose of this paper was to assess the effects of cold ischemia on levels and phosphorylation of members of the AKT and mitogen-activated protein (MAP)-kinase pathways, as well as tyrosine kinase, C-MET and epidermal growth factor receptor (EGFR) in colorectal tumor and normal adjacent specimens.
Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue.
Unger FT, Lange N, Krüger J, Compton C, Moore H, Agrawal L, Juhl H, David KA
Purpose
Conclusion
Minor but significant changes as a result of cold ischemia were limited to a decline in MEK1/2 phosphorylation after 10 min in normal adjacent specimens, a decline in ERK1/2 phosphorylation after 10 min in both tumor and normal adjacent specimens, a decline in c-MET phosphorylation after 20 min in normal adjacent specimens, and an increase in AKT phosphorylation after 45 min in normal adjacent specimens. Phosphorylation of individual protein isoforms was also significantly affected in a protein, time and cancer status specific manner.
Studies (1)
Purpose
The purpose of this study was to assess how cold ischemia influences ERK1/2, AKT, MEK 1/2, and c-MET phosphorylation in protein lysates from colorectal tumor and normal adjacent specimens. Case-matched specimens were procured from 20 patients by biopsy (designated as 0 min of cold ischemia time) and from surgically resected specimens after 10, 20, or 45 minutes of cold ischemia time. Only tumors larger than 3 cm in diameter were sampled. Macrodissection or laser cell microdissection was used to endure that each specimen had a tumor content of greater or equal to 50%. Protein lysates from 10-15 frozen sections (20 µm) were stored at -80°C prior to analysis with the NanoPro 1000 system, a automated capillary-based immunoassay.
Summary of Findings
Overall ERK 1/2 phosphorylation displayed a high degree of intra- and inter-individual variability and was significantly higher in normal adjacent compared to tumor specimens procured during biopsy (cold ischemia time of 0 min) (p≤0.05), but phosphorylation of AKT and MEK1/2 did not differ between normal adjacent and tumor specimens procured during biopsy. MEK1/2 phosphorylation declined after 10 min cold ischemia in normal adjacent specimens (p≤0.05), but other timepoints were not affected. Analysis of individual MEK1/2 isoforms revealed a significant decline in one isoform after 20 min (p≤0.05) and 2 isoforms after 45 min of ischemia (p≤0.05) in normal adjacent specimens; and significant declines in 2 isoforms of MEK1/2 in tumor specimens after 10 min or more of cold ischemia (p≤0.05 or 0.001) compared to 0 min controls. ERK1/2 phosphorylation declined after 10 min in both tumor and normal adjacent specimens (p<0.05) and an overall trend of decreased ERK 1/2 phosphorlyation with advancing cold ischemia time was observed for both tumor (0.5-fold decline) and normal adjacent (0.25-fold decline) specimens. Analysis of individual ERK 1/2 isoforms revealed decreased phosphorylation of ppERK1 and ppERK2b, and an increase in unphosphorylated ERK2 in normal adjacent specimens after 10 min (p≤0.05) or 20 min (p≤0.01) and a decrease in unphosphorylated ERK2 in tumor specimens after 20 min (p≤0.05) of ischemia compared to 0 min controls. c-MET phosphorylation was lower after 20 min of ischemia in normal adjacent specimens compared to 0 min controls (p≤0.01). Further analysis revealed a significant decline in just one c-MET isoform after 20 min of cold ischemia in normal adjacent specimens compared to 0 min controls (p≤0.05). An increase in AKT phosphorylation after 45 min compared to 0 min controls was observed in normal adjacent specimens (p≤0.05). In tumor specimens, overall AKT phosphorlyation exhibited a declining trend in 18 of the 19 patients examined after an ischemia time of 20 min or longer. When phosphorylation of individual AKT isoforms was examined, a significant increase was observed for two isoforms after 45 min of cold ischemia in normal specimens (p≤0.05); however, a different isoform declined beginning after 10 min of cold ischemia in tumor tissue (p≤0.05, 0.01 or 0.001). EGFR expression and phosphorylation were not significantly affected by up to 45 min of cold ischemia in either tumor or normal adjacent specimens.
Biospecimens
TissueColorectalPreservation Types
FrozenDiagnoses
NeoplasticCarcinomaNeoplasticNormal AdjacentPlatforms
ProteinImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Cold ischemia time 0 min10 min20 min45 minBiospecimen Acquisition Method of tissue acquisition BiopsySurgical resection